Role of Hormonal Treatment in Prostate Cancer Patients with Nonmetastatic Disease Recurrence After Local Curative Treatment: A Systematic Review.

Roderick C N van den Bergh; Niels J van Casteren; Thomas van den Broeck; Eve R Fordyce; William K M Gietzmann; Fiona Stewart; Steven MacLennan; Saeed Dabestani; Joaquim Bellmunt; Michel Bolla; Erik Briers; Philip Cornford; Steven Joniau; Malcolm D Mason; Vsevolod Matveev; Henk G van der Poel; Theo H van der Kwast; Olivier Rouvière; Thomas Wiegel; Thomas B Lam; Nicolas Mottet

doi:10.1016/j.eururo.2015.11.023

Role of Hormonal Treatment in Prostate Cancer Patients with Nonmetastatic Disease Recurrence After Local Curative Treatment: A Systematic Review.

Roderick C N van den Bergh, Niels J van Casteren, Thomas van den Broeck, Eve R Fordyce, William K M Gietzmann, Fiona Stewart, Steven MacLennan, Saeed Dabestani, Joaquim Bellmunt, Michel Bolla, Erik Briers, Philip Cornford, Steven Joniau, Malcolm D Mason, Vsevolod Matveev, Henk G van der Poel, Theo H van der Kwast, Olivier Rouvière, Thomas Wiegel, Thomas B LamNicolas Mottet

Urology

Research output: Contribution to journal › Review article › peer-review

Abstract

The relative benefits and harms of hormonal treatment (HT) versus no or deferred HT in patients with nonmetastatic prostate cancer (PCa) relapse after primary curative therapy are controversial.

Original language	English
Journal	European Urology
Early online date	2015 Dec 12
DOIs	https://doi.org/10.1016/j.eururo.2015.11.023
Publication status	Published - 2015

Subject classification (UKÄ)

Cancer and Oncology

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.eururo.2015.11.023

http://www.ncbi.nlm.nih.gov/pubmed/26691493?dopt=Abstract

Cite this

van den Bergh, R. C. N., van Casteren, N. J., van den Broeck, T., Fordyce, E. R., Gietzmann, W. K. M., Stewart, F., MacLennan, S., Dabestani, S., Bellmunt, J., Bolla, M., Briers, E., Cornford, P., Joniau, S., Mason, M. D., Matveev, V., van der Poel, H. G., van der Kwast, T. H., Rouvière, O., Wiegel, T., ... Mottet, N. (2015). Role of Hormonal Treatment in Prostate Cancer Patients with Nonmetastatic Disease Recurrence After Local Curative Treatment: A Systematic Review. European Urology. https://doi.org/10.1016/j.eururo.2015.11.023

@article{96c73a51f14e4b078d2948911d7002f4,

title = "Role of Hormonal Treatment in Prostate Cancer Patients with Nonmetastatic Disease Recurrence After Local Curative Treatment: A Systematic Review.",

abstract = "The relative benefits and harms of hormonal treatment (HT) versus no or deferred HT in patients with nonmetastatic prostate cancer (PCa) relapse after primary curative therapy are controversial.",

author = "{van den Bergh}, {Roderick C N} and {van Casteren}, {Niels J} and {van den Broeck}, Thomas and Fordyce, {Eve R} and Gietzmann, {William K M} and Fiona Stewart and Steven MacLennan and Saeed Dabestani and Joaquim Bellmunt and Michel Bolla and Erik Briers and Philip Cornford and Steven Joniau and Mason, {Malcolm D} and Vsevolod Matveev and {van der Poel}, {Henk G} and {van der Kwast}, {Theo H} and Olivier Rouvi{\`e}re and Thomas Wiegel and Lam, {Thomas B} and Nicolas Mottet",

year = "2015",

doi = "10.1016/j.eururo.2015.11.023",

language = "English",

journal = "European Urology",

issn = "1873-7560",

publisher = "Elsevier",

}

van den Bergh, RCN, van Casteren, NJ, van den Broeck, T, Fordyce, ER, Gietzmann, WKM, Stewart, F, MacLennan, S, Dabestani, S, Bellmunt, J, Bolla, M, Briers, E, Cornford, P, Joniau, S, Mason, MD, Matveev, V, van der Poel, HG, van der Kwast, TH, Rouvière, O, Wiegel, T, Lam, TB & Mottet, N 2015, 'Role of Hormonal Treatment in Prostate Cancer Patients with Nonmetastatic Disease Recurrence After Local Curative Treatment: A Systematic Review.', European Urology. https://doi.org/10.1016/j.eururo.2015.11.023

TY - JOUR

T1 - Role of Hormonal Treatment in Prostate Cancer Patients with Nonmetastatic Disease Recurrence After Local Curative Treatment: A Systematic Review.

AU - van den Bergh, Roderick C N

AU - van Casteren, Niels J

AU - van den Broeck, Thomas

AU - Fordyce, Eve R

AU - Gietzmann, William K M

AU - Stewart, Fiona

AU - MacLennan, Steven

AU - Dabestani, Saeed

AU - Bellmunt, Joaquim

AU - Bolla, Michel

AU - Briers, Erik

AU - Cornford, Philip

AU - Joniau, Steven

AU - Mason, Malcolm D

AU - Matveev, Vsevolod

AU - van der Poel, Henk G

AU - van der Kwast, Theo H

AU - Rouvière, Olivier

AU - Wiegel, Thomas

AU - Lam, Thomas B

AU - Mottet, Nicolas

PY - 2015

Y1 - 2015

N2 - The relative benefits and harms of hormonal treatment (HT) versus no or deferred HT in patients with nonmetastatic prostate cancer (PCa) relapse after primary curative therapy are controversial.

AB - The relative benefits and harms of hormonal treatment (HT) versus no or deferred HT in patients with nonmetastatic prostate cancer (PCa) relapse after primary curative therapy are controversial.

U2 - 10.1016/j.eururo.2015.11.023

DO - 10.1016/j.eururo.2015.11.023

M3 - Review article

C2 - 26691493

SN - 1873-7560

JO - European Urology

JF - European Urology

ER -

Role of Hormonal Treatment in Prostate Cancer Patients with Nonmetastatic Disease Recurrence After Local Curative Treatment: A Systematic Review.

Abstract

Subject classification (UKÄ)

UN SDGs

Access to Document

Fingerprint

Cite this